127 related articles for article (PubMed ID: 3542184)
21. [Therapy of renal cell carcinoma. 3. Interferon therapy].
Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
[TBL] [Abstract][Full Text] [Related]
22. Interferon therapy in disseminated renal cell carcinoma.
Edsmyr F; Esposti PL; Andersson L; Steineck G; Lagergren C; Strander H
Radiother Oncol; 1985 Aug; 4(1):21-6. PubMed ID: 2412262
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
[TBL] [Abstract][Full Text] [Related]
24. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
Mickisch GH; Garin A; van Poppel H; de Prijck L; Sylvester R;
Lancet; 2001 Sep; 358(9286):966-70. PubMed ID: 11583750
[TBL] [Abstract][Full Text] [Related]
25. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
[TBL] [Abstract][Full Text] [Related]
26. Combined interferon and vinblastine treatment of advanced melanoma and renal cell cancer.
Kellokumpu-Lehtinen P; Nordman E
Cancer Detect Prev; 1988; 12(1-6):523-9. PubMed ID: 3180144
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials.
Umeda T; Niijima T
Cancer; 1986 Sep; 58(6):1231-5. PubMed ID: 3742449
[TBL] [Abstract][Full Text] [Related]
28. [Histopathologic evaluation of anti-tumor activity of alpha-interferon for renal cell carcinoma, especially in autoptic cases].
Yamauchi T; Kawamura J; Yoshida O; Fukuyama T; Ogura K; Nakagawa K
Hinyokika Kiyo; 1985 Sep; 31(9):1539-52. PubMed ID: 4083212
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients.
Lopez Hänninen E; Kirchner H; Atzpodien J
J Urol; 1996 Jan; 155(1):19-25. PubMed ID: 7490829
[TBL] [Abstract][Full Text] [Related]
30. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
Ishito N; Wada F; Aramaki K; Asano S; Johsen T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
[TBL] [Abstract][Full Text] [Related]
31. Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
Eto M; Kawano Y; Hirao Y; Mita K; Arai Y; Tsukamoto T; Hashine K; Matsubara A; Fujioka T; Kimura G; Shinohara N; Tatsugami K; Hinotsu S; Naito S;
BMC Cancer; 2015 Oct; 15():667. PubMed ID: 26452347
[TBL] [Abstract][Full Text] [Related]
32. Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890).
Dutcher JP; Fine JP; Krigel RL; Murphy BA; Schaefer PL; Ernstoff MS; Loehrer PJ
Med Oncol; 2003; 20(3):271-81. PubMed ID: 14514977
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
34. Combined subcutaneous recombinant alpha-interferon and interleukin-2 in metastatic renal cell cancer: results of the Multicentre All Ireland Immunotherapy Study Group.
Rogers E; Bredin H; Butler M; Corcoran M; Egan E; Fennelly J; Grainger R; Aleer SM; Dermott TM; Mullins G; Tanner A; Twomey A; Thornhill J
Eur Urol; 2000 Mar; 37(3):261-6. PubMed ID: 10720849
[TBL] [Abstract][Full Text] [Related]
35. [Study of the effects of treatment with interferon for the advanced renal cell carcinoma based upon the survival rate].
Onishi T; Ohishi Y; Iizuka N; Shirakawa H; Suzuki Y; Suzuki H; Asano K; Hosobe T; Nakajo H; Hatano T; Makino H; Tomita M
Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):463-72. PubMed ID: 9155113
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
37. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
[TBL] [Abstract][Full Text] [Related]
38. Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study.
Fosså SD; Raabe N; Moe B
Br J Urol; 1989 Nov; 64(5):468-71. PubMed ID: 2611615
[TBL] [Abstract][Full Text] [Related]
39. Results of immunochemotherapy with interleukin-2, interferon-alpha2 and 5-fluorouracil in the treatment of metastatic renal cell cancer.
Samland D; Steinbach F; Reiher F; Schmidt U; Gruss A; Allhoff EP
Eur Urol; 1999; 35(3):204-9. PubMed ID: 10072621
[TBL] [Abstract][Full Text] [Related]
40. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
